BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02553642-completion@plaintrial.com
DTSTAMP:20261028T133755Z
DTSTART;VALUE=DATE:20240429
SUMMARY:Relationship Between Tumor Mutation Burden and Predicted Neo-antige
 n Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With
  Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) — estimated completi
 on date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02553642
URL:https://plaintrial.com/trial/NCT02553642
END:VEVENT
END:VCALENDAR